We then explored whether the reduced activity of Cdc42 is responsible for the impaired invasion of melanoma cells upon reduced WNT5A expression through gain‐of‐function experiments with the Cdc42 and Rac1 activator II. This evidence concerns the gene RAC1 and melanoma.